Clinical Trial
Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinoma
- PMID: 3882231
Item in Clipboard
Clinical Trial
Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinoma
Cancer Treat Rep.
1985 Feb.
No abstract available
Similar articles
-
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.Clin Cancer Res. 1997 Nov;3(11):1977-84. Clin Cancer Res. 1997. PMID: 9815587 Clinical Trial.
-
Phase II study of continuous 5-day vinblastine infusion in renal adenocarcinoma.Cancer Treat Rep. 1984 Jun;68(6):925-6. Cancer Treat Rep. 1984. PMID: 6733709 No abstract available.
-
[Progression of late metastases of renal cell carcinoma].Dtsch Med Wochenschr. 2006 Apr 28;131(17):994. doi: 10.1055/s-2006-939884. Dtsch Med Wochenschr. 2006. PMID: 16673224 German. No abstract available.
-
Current clinical trials in renal cell carcinoma.Urol Oncol. 2005 Jul-Aug;23(4):289-92. doi: 10.1016/j.urolonc.2005.05.007. Urol Oncol. 2005. PMID: 16018946 Review.
-
Aldesleukin for metastatic renal cell carcinoma?Drug Ther Bull. 1993 Apr 13;31(8):29-30. Drug Ther Bull. 1993. PMID: 8348884 Review. No abstract available.
Cited by
-
Metastatic renal cell cancer--is the outlook really improving?Postgrad Med J. 1990 Jun;66(776):435-40. doi: 10.1136/pgmj.66.776.435. Postgrad Med J. 1990. PMID: 1699216 Free PMC article. Review. No abstract available.
-
Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma.Invest New Drugs. 1988 Jun;6(2):97-103. doi: 10.1007/BF00195367. Invest New Drugs. 1988. PMID: 3170135
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical